These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16710669)

  • 1. First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?
    Gonzalez RR; Kaplan SA
    World J Urol; 2006 Sep; 24(4):360-6. PubMed ID: 16710669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of the bladder outlet obstruction associated with BPH in patients with special circumstances and/or complications].
    Descazeaud A; Robert G; de La Taille A
    Prog Urol; 2018 Nov; 28(15):868-874. PubMed ID: 30220535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia (BPH) management in the primary care setting.
    Kapoor A
    Can J Urol; 2012 Oct; 19 Suppl 1():10-7. PubMed ID: 23089343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative Treatment for Benign Prostatic Hyperplasia in Patients With Bladder Stones.
    Yoshida T; Kinoshita H; Nakamoto T; Yanishi M; Sugi M; Murota T; Matsuda T
    Urology; 2015 Sep; 86(3):450-3. PubMed ID: 26235850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of attitudes and expectations: Iranian patients versus urologists in the management of benign prostatic hyperplasia.
    Hosseini J; Alinejad Khorram A; Abedi AR; Hosseini MA; Fayaz M
    BMC Urol; 2024 Oct; 24(1):219. PubMed ID: 39379872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 1, Pathological Background and Clinical Implications.
    Sun F; Crisóstomo V; Báez-Díaz C; Sánchez FM
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):1-7. PubMed ID: 26581418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Benign Prostatic Hyperplasia.
    Kim EH; Larson JA; Andriole GL
    Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted laparoscopic simple anatomic prostatectomy.
    Patel MN; Hemal AK
    Urol Clin North Am; 2014 Nov; 41(4):485-92. PubMed ID: 25306160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of benign prostatic hyperplasia.
    Kane MM; Fields DW; Vaughan ED
    Urology; 1990 Nov; 36(5 Suppl):5-12. PubMed ID: 1700530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive treatment of benign prostatic hyperplasia. Where do we stand in 2005.
    Al-Ansari AA; Shokeir AA
    Saudi Med J; 2006 Mar; 27(3):299-304. PubMed ID: 16532087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.
    Liatsikos E; Kyriazis I; Kallidonis P; Stolzenburg JU
    Aging Male; 2011 Sep; 14(3):141-9. PubMed ID: 21247241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia in older men.
    Gerber GS
    Clin Geriatr Med; 1998 May; 14(2):317-31. PubMed ID: 9536108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of symptomatic benign prostatic hyperplasia--today.
    Barkin J
    Can J Urol; 2008 Dec; 15(6):4353-8. PubMed ID: 19046487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.